Doxorubicin-related CHF more frequent than previously reported
The utility of doxorubicin is limited by the risk of cumulative, dose-related, progressive myocardial damage.
Newsletter
Get the latest industry news, event updates, and more from Managed healthcare Executive.
Recent Videos
Related Content
